Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Ridgeback Capital Investments L.P. (CIK 1423994) reported $560,400 across 1 reported positions in its SEC 13F filing for 2024-12-31. Largest positions: PYXS ($560,400, 100.00%), BCYC ($0, 0.00%), AFMD ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PYXS | Pyxis Oncology Inc | $560,400 | 100.00% | 359,231 | New |
| 2 | BCYC | BICYCLE THERAPEUTICS LTD. | $0 | 0.00% | 0 | Exited |
| 3 | AFMD | AFFIMED NV | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2024-12-31